top of page

Insights
Subscribe to blog
Subscribe to my blog to get Insights in your Inbox


Alphabet Is Rethinking Board Risk Oversight—Should You As Well?
July 11, 2025 | By Mary Kohler in Bloomberg Law Life sciences attorney Mary Kohler says boards with standalone risk committees...


Kohler Health Law Recognized in Chambers & Partners USA Spotlight Guide
Kohler Health Law is honored to be recognized by Chambers and Partners USA: Spotlight Guide 2025 for excellence in Healthcare Law in California.


2 Anti-Kickback Developments Hold Lessons for Biopharma
February 13, 2025 | By Mary Kohler in Law360 Last year ushered in new Anti-Kickback Statute concerns for biopharma companies after...


Remarks Delivered at Public Meeting on FDA's Rare Disease Innovation Hub
October 16, 2024 Attorney Mary Kohler was invited to comment during a public meeting on FDA's plan to launch a Rare Disease Innovation...


Vertex Suit Highlights Issues for Pharma Fertility Support
September 19, 2024 | By Mary Kohler in Law360 On July 15, Vertex Pharmaceuticals Inc. sued the U.S. Department of Health and Human...
bottom of page